AMINOPYRAZOLE TRIAZOLOTHIADIAZOLE INHIBITOR OF C-MET PROTEIN KINASE

The present invention relates to anhydrous and hydrated forms of Compound 1, which qre useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising compounds of formula I and methods of using the compositions in the treatment of pr...

Full description

Saved in:
Bibliographic Details
Main Authors ROEPER STEFANIE, LAUFFER DAVID J, MILLER, JR. DAVID B, SHI YI, IBRAHIM SHEREEN, KULDIPKUMAR ANUJ K, LI PAN
Format Patent
LanguageEnglish
Published 01.12.2011
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present invention relates to anhydrous and hydrated forms of Compound 1, which qre useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising compounds of formula I and methods of using the compositions in the treatment of proliferative disorders.
AbstractList The present invention relates to anhydrous and hydrated forms of Compound 1, which qre useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising compounds of formula I and methods of using the compositions in the treatment of proliferative disorders.
Author KULDIPKUMAR ANUJ K
LAUFFER DAVID J
IBRAHIM SHEREEN
SHI YI
ROEPER STEFANIE
LI PAN
MILLER, JR. DAVID B
Author_xml – fullname: ROEPER STEFANIE
– fullname: LAUFFER DAVID J
– fullname: MILLER, JR. DAVID B
– fullname: SHI YI
– fullname: IBRAHIM SHEREEN
– fullname: KULDIPKUMAR ANUJ K
– fullname: LI PAN
BookMark eNrjYmDJy89L5WRwdvT19PMPiAxyjPL3cVUICfIEMfxDPDwdXTwhYp5-Hp5OniH-QQr-bgrOur6uIQoBQf4hrp5-Ct6efo7BrjwMrGmJOcWpvFCam0HZzTXE2UM3tSA_PrW4IDE5NS-1JD402MjA0NDI0sTCxNLR0Jg4VQA-MC6n
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2011294849A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2011294849A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:29:38 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2011294849A13
Notes Application Number: US201113114215
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111201&DB=EPODOC&CC=US&NR=2011294849A1
ParticipantIDs epo_espacenet_US2011294849A1
PublicationCentury 2000
PublicationDate 20111201
PublicationDateYYYYMMDD 2011-12-01
PublicationDate_xml – month: 12
  year: 2011
  text: 20111201
  day: 01
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies KULDIPKUMAR ANUJ K
LAUFFER DAVID J
IBRAHIM SHEREEN
SHI YI
ROEPER STEFANIE
LI PAN
MILLER, JR. DAVID B
VERTEX PHARMACEUTICALS INCORPORATED
RelatedCompanies_xml – name: SHI YI
– name: IBRAHIM SHEREEN
– name: VERTEX PHARMACEUTICALS INCORPORATED
– name: LAUFFER DAVID J
– name: LI PAN
– name: ROEPER STEFANIE
– name: KULDIPKUMAR ANUJ K
– name: MILLER, JR. DAVID B
Score 2.831954
Snippet The present invention relates to anhydrous and hydrated forms of Compound 1, which qre useful in the inhibition of c-Met protein kinase. The invention also...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title AMINOPYRAZOLE TRIAZOLOTHIADIAZOLE INHIBITOR OF C-MET PROTEIN KINASE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111201&DB=EPODOC&locale=&CC=US&NR=2011294849A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivqmU_FjSkHpW3HrR7o-DOnSlEZsU7pOpi8j6VIQpBuu4r9vGjfd017CcQfHJXC53C-5CwD3A25aBfdcg0FLJigWFAbnHjME7A1s5kBuzhtoIE5gNLGfps60BT42tTCqT-i3ao4oPaqQ_l6r_Xr5D2IF6m3l6oG_S9biMcyHgT7fwH19OejBaIhTGlCkIzScjPUkUzLTswe258tcaU8epN3GH_DLqKlLWW4HlfAY7KdSX1WfgJaoOuAQbf5e64CDeH3lLcm1961OAfJjktD0NfPf6DPW8ow0BM0j4gfkl0eSiIxITjONhhoyYpxraUZzTBJN5un-GJ-BuxDnKDKkNbO_yc8m423TrXPQrhaVuAAac5lgom85LoO2V7qsLHtmaRUe5M5cxqNL0N2l6Wq3-BocKfRUPdzognb9-SVuZPit-a1atR-sz4Lw
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQWlb8Wtn-vDkK4fNLo2pctk-lKSrQVBuuEq_vumcdM97SUcd3BcApfL_ZK7ANz3marNmG0p1NR4gqKZucKYTZXc7PZ1aphMndfQQBSb4UR_mhrTBnxsamFEn9Bv0RyRe9SM-3sl9uvlP4jlibeVqwf2zlmLx4AMPHm-gft6fJC94cBPsIdd2XUHk7Ecp0Km2npftx2eK-3xQ7ZV-4P_MqzrUpbbQSU4gv2E6yurY2jkZRta7ubvtTYcROsrb06uvW91Aq4ToRgnr6nzhke-RFJUE5iEyPHQLw_FIRoiglMJB5KrRD6RkhQTH8USz9OdsX8Kd4FP3FDh1mR_k88m423TtTNolosyPweJWjSneU8zLGrqdmHRouiqhTazTWbMeTy6gM4uTZe7xbfQCkk0ykYofr6CQ4GkikccHWhWn1_5NQ_FFbsRK_gD_T2F4w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=AMINOPYRAZOLE+TRIAZOLOTHIADIAZOLE+INHIBITOR+OF+C-MET+PROTEIN+KINASE&rft.inventor=ROEPER+STEFANIE&rft.inventor=LAUFFER+DAVID+J&rft.inventor=MILLER%2C+JR.+DAVID+B&rft.inventor=SHI+YI&rft.inventor=IBRAHIM+SHEREEN&rft.inventor=KULDIPKUMAR+ANUJ+K&rft.inventor=LI+PAN&rft.date=2011-12-01&rft.externalDBID=A1&rft.externalDocID=US2011294849A1